DISCO Pharmaceuticals: Revolutionizing Cancer Treatment through Surfaceome Mapping

DISCO Pharmaceuticals, a pioneering biotech company, has officially emerged from stealth mode with a breakthrough technology aimed at unlocking the surfaceome of cancer cells. This revolutionary approach facilitates the identification of new targets and the development of first-in-class drugs. Headquartered in Cologne, Germany, and Schlieren, Switzerland, DISCO has successfully secured seed financing of EUR 20…

Read More